BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27760426)

  • 1. Cl-NQTrp Alleviates Tauopathy Symptoms in a Model Organism through the Inhibition of Tau Aggregation-Engendered Toxicity.
    Frenkel-Pinter M; Tal S; Scherzer-Attali R; Abu-Hussien M; Alyagor I; Eisenbaum T; Gazit E; Segal D
    Neurodegener Dis; 2017; 17(2-3):73-82. PubMed ID: 27760426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naphthoquinone-Tryptophan Hybrid Inhibits Aggregation of the Tau-Derived Peptide PHF6 and Reduces Neurotoxicity.
    Frenkel-Pinter M; Tal S; Scherzer-Attali R; Abu-Hussien M; Alyagor I; Eisenbaum T; Gazit E; Segal D
    J Alzheimers Dis; 2016; 51(1):165-78. PubMed ID: 26836184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic insights into remodeled Tau-derived PHF6 peptide fibrils by Naphthoquinone-Tryptophan hybrids.
    KrishnaKumar VG; Paul A; Gazit E; Segal D
    Sci Rep; 2018 Jan; 8(1):71. PubMed ID: 29311706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naphthoquinone-tyrptophan reduces neurotoxic Aβ*56 levels and improves cognition in Alzheimer's disease animal model.
    Scherzer-Attali R; Farfara D; Cooper I; Levin A; Ben-Romano T; Trudler D; Vientrov M; Shaltiel-Karyo R; Shalev DE; Segev-Amzaleg N; Gazit E; Segal D; Frenkel D
    Neurobiol Dis; 2012 Jun; 46(3):663-72. PubMed ID: 22449754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purpurin modulates Tau-derived VQIVYK fibrillization and ameliorates Alzheimer's disease-like symptoms in animal model.
    Viswanathan GK; Shwartz D; Losev Y; Arad E; Shemesh C; Pichinuk E; Engel H; Raveh A; Jelinek R; Cooper I; Gosselet F; Gazit E; Segal D
    Cell Mol Life Sci; 2020 Jul; 77(14):2795-2813. PubMed ID: 31562564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylations of tryptophan-modified naphthoquinone affect its inhibitory potential toward Aβ aggregation.
    Scherzer-Attali R; Convertino M; Pellarin R; Gazit E; Segal D; Caflisch A
    J Phys Chem B; 2013 Feb; 117(6):1780-9. PubMed ID: 23259849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased O-GlcNAcylation reduces pathological tau without affecting its normal phosphorylation in a mouse model of tauopathy.
    Graham DL; Gray AJ; Joyce JA; Yu D; O'Moore J; Carlson GA; Shearman MS; Dellovade TL; Hering H
    Neuropharmacology; 2014 Apr; 79():307-13. PubMed ID: 24326295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular structure of the NQTrp inhibitor with the Alzheimer Aβ1-28 monomer.
    Tarus B; Nguyen PH; Berthoumieu O; Faller P; Doig AJ; Derreumaux P
    Eur J Med Chem; 2015 Feb; 91():43-50. PubMed ID: 25011560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of tau aggregation in a novel Caenorhabditis elegans model of tauopathy mitigates proteotoxicity.
    Fatouros C; Pir GJ; Biernat J; Koushika SP; Mandelkow E; Mandelkow EM; Schmidt E; Baumeister R
    Hum Mol Genet; 2012 Aug; 21(16):3587-603. PubMed ID: 22611162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atomic and dynamic insights into the beneficial effect of the 1,4-naphthoquinon-2-yl-L-tryptophan inhibitor on Alzheimer's Aβ1-42 dimer in terms of aggregation and toxicity.
    Zhang T; Xu W; Mu Y; Derreumaux P
    ACS Chem Neurosci; 2014 Feb; 5(2):148-59. PubMed ID: 24246047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration.
    Amadoro G; Corsetti V; Stringaro A; Colone M; D'Aguanno S; Meli G; Ciotti M; Sancesario G; Cattaneo A; Bussani R; Mercanti D; Calissano P
    J Alzheimers Dis; 2010; 21(2):445-70. PubMed ID: 20571215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory RNA Aptamers of Tau Oligomerization and Their Neuroprotective Roles against Proteotoxic Stress.
    Kim JH; Kim E; Choi WH; Lee J; Lee JH; Lee H; Kim DE; Suh YH; Lee MJ
    Mol Pharm; 2016 Jun; 13(6):2039-48. PubMed ID: 27120117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin promotes tau aggregation and exacerbates abnormal behavior in a mouse model of tauopathy.
    Barini E; Antico O; Zhao Y; Asta F; Tucci V; Catelani T; Marotta R; Xu H; Gasparini L
    Mol Neurodegener; 2016 Feb; 11():16. PubMed ID: 26858121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tauopathies and tau oligomers.
    Takashima A
    J Alzheimers Dis; 2013; 37(3):565-8. PubMed ID: 23948895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylene Blue Inhibits Formation of Tau Fibrils but not of Granular Tau Oligomers: A Plausible Key to Understanding Failure of a Clinical Trial for Alzheimer's Disease.
    Soeda Y; Saito M; Maeda S; Ishida K; Nakamura A; Kojima S; Takashima A
    J Alzheimers Dis; 2019; 68(4):1677-1686. PubMed ID: 30909223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing tau aggregates with anle138b delays disease progression in a mouse model of tauopathies.
    Wagner J; Krauss S; Shi S; Ryazanov S; Steffen J; Miklitz C; Leonov A; Kleinknecht A; Göricke B; Weishaupt JH; Weckbecker D; Reiner AM; Zinth W; Levin J; Ehninger D; Remy S; Kretzschmar HA; Griesinger C; Giese A; Fuhrmann M
    Acta Neuropathol; 2015 Nov; 130(5):619-31. PubMed ID: 26439832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinctive alteration in the expression of autophagy genes in Drosophila models of amyloidopathy and tauopathy.
    Haghi M; Masoudi R; Najibi SM
    Ups J Med Sci; 2020 Nov; 125(4):265-273. PubMed ID: 32657227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prefibrillar Tau oligomers alter the nucleic acid protective function of Tau in hippocampal neurons in vivo.
    Violet M; Chauderlier A; Delattre L; Tardivel M; Chouala MS; Sultan A; Marciniak E; Humez S; Binder L; Kayed R; Lefebvre B; Bonnefoy E; Buée L; Galas MC
    Neurobiol Dis; 2015 Oct; 82():540-551. PubMed ID: 26385829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An amyloidogenic hexapeptide from the cataract-associated γD-crystallin is a model for the full-length protein and is inhibited by naphthoquinone-tryptophan hybrids.
    Abu-Hussien M; Viswanathan GK; Haj E; Paul A; Gazit E; Segal D
    Int J Biol Macromol; 2020 Aug; 157():424-433. PubMed ID: 32302630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory Effect of Naphthoquinone-Tryptophan Hybrid towards Aggregation of PAP f39 Semen Amyloid.
    Viswanathan GK; Mohapatra S; Paul A; Arad E; Jelinek R; Gazit E; Segal D
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30544943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.